期刊文献+

甘丙肽2型受体激动剂对慢性温和应激模型大鼠抑郁样行为的影响

Effects of Galanin Receptor 2 Agonist on Depression-like Behavior in Chronic Mild Stress Model Rats
下载PDF
导出
摘要 目的侧脑室注射甘丙肽2型受体(Gal R2)激动剂AR-M1896,探讨其对慢性温和应激模型(CMS)大鼠抑郁样行为的影响。方法 48只Sprague-Dawley大鼠随机等分为对照组、CMS组、CMS人工脑脊液(a CSF)组、CMS AR-M1896组。对照组不作任何处理,其他3组制备大鼠慢性温和应激模型。应激6周后,通过强迫游泳及糖水偏好实验验证抑郁样行为;挑选造模成功大鼠,CMSaCSF组和CMS AR-M1896组侧脑室分别注射a CSF和AR-M1896。观察强迫游泳实验中的不动时间、攀爬时间,以及糖水偏好实验中的糖水饮用百分比。结果与CMSaCSF组相比,CMS AR-M1896组不动时间明显缩短(F=11.998,P<0.01),攀爬时间延长(F=8.268,P<0.05),糖水饮用百分比明显增加(F=10.352,P<0.01)。结论侧脑室注射AR-M1896可对慢性温和应激模型大鼠产生抗抑郁作用。 Objective To explore the effect of intracerebroventricular injection of AR-M1896, a galanin receptor 2 agonist, on depression- like behavior in rat chronic mild stress(CMS) model. Methods 48 Sprague- Dawley rats were randomly assigned into control group,CMS group, CMS artificial cerebrospinal fluid(a CSF) group and CMS AR-M1896 group equally. The control group received no intervention, and the other groups were established chronic mild stress model. After six-week of stress, forced swim test and sucrose preference test were conducted to identify the CMS rats. AR-M1896 oraCSF was injected into the lateral ventricle of CMS AR-M1896 group and CMSaCSF group, respectively. The immobility time and climbing time in the forced swim test were analysed, and the sucrose consumption percentage in the sucrose preference test was measured. Results The immobility time decreased(F=11.998, P〈0.01), climbing time increased(F=8.268, P〈0.05), and the sucrose consumption percentage increased(F=10.352, P〈0.01) in CMS AR-M1896 group, compared with CMSaCSF group. Conclusion Intracerebroventricular administration of galanin receptor 2 agonist AR- M1896 is effective on depression in CMS model rats.
出处 《中国康复理论与实践》 CSCD 北大核心 2016年第3期278-281,共4页 Chinese Journal of Rehabilitation Theory and Practice
基金 国家自然科学基金面上项目(No.31171032)
关键词 慢性温和应激 抑郁 甘丙肽2型受体激动剂 大鼠 chronic mild stress depression galanin receptor 2 agonist rats
  • 相关文献

参考文献24

  • 1Cassano P, Fava M. Depression and public health: an over- view [J]. J Psychosom Res, 2002, 53(4): 849-857.
  • 2Dennis CL, Dowswell T. Interventions (other than pharmaco- logical, psychosocial or psychological) for treating antenatal depression [J]. Cochrane Database Syst Rev, 2013, 7: D6795.
  • 3Yatemoto K, Rokaeus A, Jornvall H, et al. Galanin - a novel bio- logically active peptide from porcine intestine [J]. FEBS Lett, 1983, 164(1): 124-128.
  • 4Freimann K, Kurrikoff K, Langel U. Galanin receptors as a po- tential target for neurological disease [J]. Expert Opin Ther Tar- gets, 2015, 19(12): 1665-1676.
  • 5Xu ZQ, Shi T J, Hokfelt T. Galanin/GMAP- and NPY-like im- munoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin-R1 and -R2 receptors [J]. J Comp Neurol, 1998, 392(2): 227-251.
  • 6Xu ZQ, Zhang X, Pieribone VA, et al. Galanin-5-hydroxytrypta- mine interactions: electrophysiological, immunohistochemical and in situ hybridization studies on rat dorsal raphe neurons with a note on galanin R1 and R2 receptors [J]. Neuroscience, 1998, 87(1): 79-94.
  • 7Webling KE, Runesson J, Bartfai T, et al. Galanin receptors and ligands [J]. Front Endocrinol (Lausanne), 2012, 3: 146.
  • 8Kuteeva E, Hokfelt T, Wardi T, et al. Galanin, galanin receptor subtypes and depression-like behaviour [J]. EXS, 2010, 102: 163-181.
  • 9王永军,杨予涛,徐志卿,王传跃.甘丙肽在抑郁症病理机制中的研究进展[J].国际精神病学杂志,2012,39(3):162-165. 被引量:3
  • 10Kuteeva E, Wardi T, Hokfelt T, et al. Galanin enhances and a galanin antagonist attenuates depression-like behaviour in the rat [J]. Eur Neuropsychopharmacol, 2007, 17(1): 64-69.

二级参考文献55

  • 1徐世莲,刘彤.甘丙肽对大鼠脊髓背角广动力范围神经元放电的影响[J].昆明医学院学报,2004,25(3):16-18. 被引量:2
  • 2张建斌,王玲玲,吕梅,刘兰英,利达.针刺对抑郁症模型大鼠行为学的影响[J].南京中医药大学学报,2005,21(1):36-39. 被引量:7
  • 3张烨,单良,娄向新,袁崇刚.甘丙肽提高离体海马神经细胞在过氧化氢损伤中的存活率[J].分子细胞生物学报,2006,39(5):391-398. 被引量:7
  • 4陆盈盈,高良才,袁崇刚.D-半乳糖致老年性痴呆模型的评价和海马脑区甘丙肽表达研究[J].中国神经免疫学和神经病学杂志,2007,14(4):191-193. 被引量:21
  • 5Counts SE, Perez SE, Mufson EJ. Galanin in Alzheimer's dis- ease: neuroinhibitory or neuroprotective [J]. Cell Mol Life Sci, 2008, 65 (12): 1842-1853.
  • 6Wraith DC, Pope R, Butzkueven H, et al. A role for galanin in human and experimental inflammatory demyelination [J]. Proc Natl Aacd Sci USA, 2009, 106 (36): 15466-15471.
  • 7Page AJ, Slattery JA, Brierley SM, et al. Involvement of galanin receptors 1 and 2 in the modulation of mouse vagal afferent mechanosensitivity [J]. J Physiol, 2007, 583 (Pt2): 675-684.
  • 8Kanazawa T, Kommareddi PK, Iwashita T, et al. Galanin recep- tor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cell [J]. Clin Cancer Res, 2009, 15 (7): 2222-2230.
  • 9McDonald AC, Schuijers JA, Gundlach AL, et al. Galanin treat- ment offsets the inhibition of bone formation and downregulates the increase in mouse calvarial expression of TNF alpha and GalR2 mRNA induced by chronic daily injections of an injurious vehicle [J]. Bone, 2007, 40 (4): 895-903.
  • 10Gottsch ML, Zeng HK, Hohmann JG, et al. Phenotypic analysis of mice deficient in the type 2 Galanin receptor (GALR2) [J]. Mol Cell Biol, 2005, 25 (11): 4804-4811.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部